SI2229172T1 - Tikagrelor za zdravljenje anevrizem abdominalne aorte - Google Patents

Tikagrelor za zdravljenje anevrizem abdominalne aorte

Info

Publication number
SI2229172T1
SI2229172T1 SI200831311T SI200831311T SI2229172T1 SI 2229172 T1 SI2229172 T1 SI 2229172T1 SI 200831311 T SI200831311 T SI 200831311T SI 200831311 T SI200831311 T SI 200831311T SI 2229172 T1 SI2229172 T1 SI 2229172T1
Authority
SI
Slovenia
Prior art keywords
ticagrelor
treatment
abdominal aortic
aortic aneurysms
aneurysms
Prior art date
Application number
SI200831311T
Other languages
English (en)
Inventor
Jean-Baptiste Michel
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SI2229172T1 publication Critical patent/SI2229172T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200831311T 2007-12-03 2008-12-02 Tikagrelor za zdravljenje anevrizem abdominalne aorte SI2229172T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07301616 2007-12-03
PCT/SE2008/051386 WO2009072967A1 (en) 2007-12-03 2008-12-02 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms
EP08857354.8A EP2229172B1 (en) 2007-12-03 2008-12-02 Ticagrelor for treatment of abdominal aortic aneurysms

Publications (1)

Publication Number Publication Date
SI2229172T1 true SI2229172T1 (sl) 2014-12-31

Family

ID=40717966

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831311T SI2229172T1 (sl) 2007-12-03 2008-12-02 Tikagrelor za zdravljenje anevrizem abdominalne aorte

Country Status (25)

Country Link
US (2) US20100298350A1 (sl)
EP (1) EP2229172B1 (sl)
JP (1) JP5701060B2 (sl)
KR (1) KR101563757B1 (sl)
CN (2) CN103919781A (sl)
AU (1) AU2008331984B2 (sl)
BR (1) BRPI0819458A2 (sl)
CA (1) CA2707488C (sl)
CY (1) CY1115760T1 (sl)
DK (1) DK2229172T3 (sl)
EA (1) EA201000928A1 (sl)
ES (1) ES2522317T3 (sl)
HK (1) HK1148195A1 (sl)
HR (1) HRP20141081T1 (sl)
IL (1) IL205613A (sl)
MX (1) MX2010006101A (sl)
MY (1) MY159656A (sl)
NZ (1) NZ585513A (sl)
PL (1) PL2229172T3 (sl)
PT (1) PT2229172E (sl)
RS (1) RS53635B1 (sl)
SI (1) SI2229172T1 (sl)
UA (1) UA100864C2 (sl)
WO (1) WO2009072967A1 (sl)
ZA (1) ZA201003599B (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102653539B (zh) * 2011-03-01 2014-09-17 秦引林 一种抗血小板聚集化合物及其药物组合
CN102924457A (zh) * 2011-08-12 2013-02-13 上海恒瑞医药有限公司 三唑并嘧啶类衍生物、其制备方法及其用途
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL182680B1 (pl) * 1995-07-11 2002-02-28 Astrazeneca Ab Nowe inhibitory skupiania się płytek krwi
TW530058B (en) * 1997-07-22 2003-05-01 Astra Pharma Prod Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist

Also Published As

Publication number Publication date
EA201000928A1 (ru) 2010-12-30
PT2229172E (pt) 2014-11-03
KR20100099175A (ko) 2010-09-10
IL205613A (en) 2015-04-30
EP2229172B1 (en) 2014-09-10
AU2008331984A1 (en) 2009-06-11
EP2229172A1 (en) 2010-09-22
ZA201003599B (en) 2012-10-31
US20150272955A1 (en) 2015-10-01
EP2229172A4 (en) 2012-12-26
AU2008331984B2 (en) 2012-08-16
CN103919781A (zh) 2014-07-16
CY1115760T1 (el) 2017-01-25
JP5701060B2 (ja) 2015-04-15
IL205613A0 (en) 2010-11-30
NZ585513A (en) 2012-07-27
CN101883565A (zh) 2010-11-10
CA2707488A1 (en) 2009-06-11
MX2010006101A (es) 2010-10-04
WO2009072967A1 (en) 2009-06-11
CA2707488C (en) 2015-07-28
ES2522317T3 (es) 2014-11-14
UA100864C2 (uk) 2013-02-11
BRPI0819458A2 (pt) 2015-05-05
KR101563757B1 (ko) 2015-10-27
DK2229172T3 (da) 2014-11-10
US20100298350A1 (en) 2010-11-25
PL2229172T3 (pl) 2015-01-30
HRP20141081T1 (hr) 2015-01-02
HK1148195A1 (en) 2011-09-02
RS53635B1 (en) 2015-04-30
JP2011505417A (ja) 2011-02-24
MY159656A (en) 2017-01-13

Similar Documents

Publication Publication Date Title
EP2285308A4 (en) DEVICES AND METHODS FOR TREATING ANEURYSMS OF ABORIGINAL AORTA
IL209998A0 (en) Abdominal aortic aneurysms: systems and methods of use
HK1207578A1 (en) Treatment of synucleinopathies
IL200271A0 (en) Endoluminal prosthesis
IL202095A0 (en) Vascular stent
EP3586794C0 (en) DEVICE FOR THE TREATMENT OF AN ANEURYSMA
GB2454797B (en) Treatment of wastewater
EP2313146A4 (en) DEVICES FOR TREATING VASCULAR ANEVRYSM
EP2429454A4 (en) MODULAR LOW PROFILE FOR ANEURYSMS OF THE ABDOMINALAORTA
GB2471517B (en) Implant deployment catheter
IL197315A0 (en) Treatment of cancer
HK1129600A1 (en) Treatment of excessive neovascularization
GB0817067D0 (en) Intestinal treatment
ZA201000225B (en) Treatment of depression
HK1148195A1 (en) Ticagrelor for treatment of abdominal aortic aneurysms
EP2182976A4 (en) TREATMENT OF AUTOIMMUNE DISEASES
GB0723100D0 (en) Treatment of HFnEF
EP2164494A4 (en) Methods of Treatment
EP2142256A4 (en) TREATMENT OF ADIPOSITAS
EP2214485A4 (en) METHOD FOR THE TREATMENT OF CANCER
EP2203432A4 (en) PROCESSING METHOD
GB0600903D0 (en) Treatment of cancer
IL217529A0 (en) Intraluminal polymeric devices for the treatment of aneurysms
GB0700969D0 (en) Methods of treatment
GB0711503D0 (en) Abdominal surgical retractor - secures intestines